Select Page

New study from Switzerland will allow for a better understanding of corneal cross-linking

Investigative Ophthalmology & Visual Science.

New research from ELZA members opens up new alleys to study the molecular events underlying corneal cross-linking.
“By being able to study the effect of CXL in the mouse, we now have a powerful tool to investigate the underlying molecular changes that occur during cross-linking. Hopefully,this will help to develop new treatment strategies to  make CXL even more efficient”
, says Farhad Hafezi, Medical Director of the ELZA Institute, and Professor of Ophthalmology at the Universities of Geneva, Switzerland, and USC Los Angeles, USA. Read the article here.


The ELZA Institute

DE |